Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients. [electronic resource]
Producer: 20200915Description: 1739-1749 p. digitalISSN:- 1473-5571
- Anti-HIV Agents -- adverse effects
- CD4 Lymphocyte Count
- Drug Therapy, Combination
- HIV Infections -- drug therapy
- HIV-1
- Heterocyclic Compounds, 3-Ring -- adverse effects
- Humans
- Lamivudine -- adverse effects
- Oxazines
- Piperazines
- Pyridones
- RNA, Viral -- blood
- Randomized Controlled Trials as Topic
- Viral Load
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.